Company has no debt since last 5 years. (Source: Consolidated Financials)
Jupiter Infomedia Share Price
Jupiter Infomedia Share...
Jupiter Infomed share price insights
Company has spent less than 1% of its operating revenues towards interest expenses and 24.23% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock gave a 3 year return of 70.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Jupiter Infomedia Ltd. share price moved down by -0.24% from its previous close of Rs 40.59. Jupiter Infomedia Ltd. stock last traded price is 40.49
Share Price Value Today/Current/Last 40.49 Previous Day 40.59
Key Metrics
PE Ratio (x) | 6.25 | ||||||||||
EPS - TTM (₹) | 6.48 | ||||||||||
MCap (₹ Cr.) | 40.57 | ||||||||||
Sectoral MCap Rank | 60 | ||||||||||
PB Ratio (x) | 1.24 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 1.37 | ||||||||||
VWAP (₹) | 39.96 | ||||||||||
52W H/L (₹) |
Jupiter Infomed Share Price Returns
1 Day | -0.24% |
1 Week | 3.37% |
1 Month | 10.75% |
3 Months | 15.16% |
1 Year | 95.04% |
3 Years | 70.84% |
5 Years | -27.63% |
Jupiter Infomed News & Analysis
NewsSensex rises! These stocks gained over 10% on BSE
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcements- Announcements
- Announcements
Jupiter Infomed Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Jupiter Infomed Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 24.23% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 5.18 7.56 2.30 3.32 3.35 Total Income Growth (%) -31.46 229.00 -30.76 -0.93 -27.54 Total Expenses 1.13 3.48 0.80 0.60 0.51 Total Expenses Growth (%) -67.42 336.01 32.59 19.29 -61.88 EBIT 4.05 4.08 1.50 2.72 2.85 EBIT Growth (%) -0.75 172.00 -44.80 -4.52 -13.75 Profit after Tax (PAT) 2.77 1.08 0.97 1.67 1.74 PAT Growth (%) 156.41 11.40 -41.94 -3.83 9.42 EBIT Margin (%) 78.11 53.94 65.25 81.85 84.93 Net Profit Margin (%) 53.46 14.29 42.21 50.34 51.86 Basic EPS (₹) 2.77 1.08 0.97 1.67 1.73 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 34.30 24.96 18.55 10.25 9.88 Total Assets Growth (%) 37.43 34.55 81.03 3.69 -12.41 Total Liabilities 1.78 1.45 - - - Total Liabilities Growth (%) 22.60 - - - - Total Equity 32.52 23.51 18.27 10.23 9.84 Total Equity Growth (%) 38.34 28.69 78.54 3.99 -7.39 Current Ratio (x) 10.61 6.96 16.17 113.46 27.28 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 - 0.28 0.28 - All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 1.98 cr for investing activities which is an YoY increase of 91.39%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 6.34 2.27 -0.24 -0.44 -0.23 Net Cash used in Investing Activities -1.98 -1.03 -6.91 0.42 0.93 Net Cash flow from Financing Activities -0.01 -0.01 7.57 - -0.66 Net Cash Flow 4.35 1.22 0.42 -0.02 0.04 Closing Cash & Cash Equivalent 6.06 1.71 0.49 0.07 0.08 Closing Cash & Cash Equivalent Growth (%) 254.08 249.21 623.16 -19.70 104.69 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 23.85% in year ending Mar 31, 2024 outperforming its 5 year avg. of 14.18%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 23.85 30.08 1.73 3.83 -7.97 Return on Capital Employed (%) 33.49 26.67 3.04 6.57 -9.83 Return on Assets (%) 15.91 20.99 1.31 3.83 -7.94 Interest Coverage Ratio (x) 2,555.04 1,662.48 0.00 0.00 -15.18 Asset Turnover Ratio (x) 0.16 0.02 0.00 0.02 0.02 Price to Earnings (x) 6.62 3.35 86.96 76.92 -27.32 Price to Book (x) 1.58 1.01 1.50 2.94 2.17 EV/EBITDA (x) 3.45 3.30 32.35 37.03 -26.49 EBITDA Margin (%) 239.73 123.46 17.61 83.28 -51.98
Jupiter Infomed Peer Comparison
Jupiter Infomed Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 70.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 70.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Jupiter Infomed Board Meeting/AGM
Jupiter Infomed Dividends
- Others
Meeting Date Announced on Purpose Details Aug 12, 2024 Aug 05, 2024 Board Meeting Quarterly Results May 08, 2024 May 02, 2024 Board Meeting Audited Results Jan 24, 2024 Jan 18, 2024 Board Meeting Quarterly Results Nov 02, 2023 Oct 25, 2023 Board Meeting Quarterly Results Aug 17, 2023 Jul 14, 2023 AGM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 1% 0.1 Sep 20, 2017 May 15, 2017 Final 1% 0.1 Aug 27, 2015 May 15, 2015 Final 1% 0.1 May 23, 2014 May 19, 2014 Final 1% 0.1 Jul 16, 2013 May 02, 2013 All Types Ex-Date Record Date Announced on Details Bonus Sep 29, 2014 Sep 30, 2014 Aug 18, 2014 Bonus Ratio: 1 share(s) for every 1 shares held
About Jupiter Infomed
Jupiter Infomedia Ltd., incorporated in the year 2005, is a Small Cap company (having a market cap of Rs 40.57 Crore) operating in Media & Entertainment sector. Jupiter Infomedia Ltd. key Products/Revenue Segments include Media Entertainment for the year ending 31-Mar-2023. Show More
Executives
Auditors
- UV
Umesh Vasantlal Modi
Chairman & Managing DirectorMUManisha Umesh Modi
WholeTime Director & CFOACAkshay Chotubhai Desai
Independent DirectorAMAnilkumar Mohanlal Agrawal
Independent DirectorShow More - Ladha Singhal & AssociatesNGS & Co. LLP
Industry
Key Indices Listed on
-
Address
336, Laxmi Plaza,Laxmi Industrial Estate,Mumbai, Maharashtra - 400053
More Details
FAQs about Jupiter Infomed share
- 1. What is Jupiter Infomed share price and what are the returns for Jupiter Infomed share?As on 29 Aug, 2024, 03:29 PM IST Jupiter Infomed share price was down by 0.24% basis the previous closing price of Rs 42.35. Jupiter Infomed share price was Rs 40.49. Return Performance of Jupiter Infomed Shares:
- 1 Week: Jupiter Infomed share price moved up by 3.37%
- 3 Month: Jupiter Infomed share price moved up by 15.16%
- 6 Month: Jupiter Infomed share price moved down by 7.20%
- 2. Who's the owner of Jupiter Infomed?Promoter owns 70.73, shares of Jupiter Infomed as on 30 Jun 2024
- There is no change in promoter holding from 31 Mar 2024 to 30 Jun 2024
- There is no change in Other investor holding from 31 Mar 2024 to 30 Jun 2024
- 3. What's the market capitalization of Jupiter Infomed?Within the Media & Entertainment sector, Jupiter Infomed stock has a market cap rank of 60. Jupiter Infomed has a market cap of Rs 40.57 Cr.
- 4. What is 52 week high/low of Jupiter Infomed share price?52 Week high of Jupiter Infomed share is Rs 57.98 while 52 week low is Rs 19.55
- 5. Who is the chairman of Jupiter Infomed?Umesh Vasantlal Modi is the Chairman & Managing Director of Jupiter Infomed
- 6. What are the Jupiter Infomed quarterly results?Total Revenue and Earning for Jupiter Infomed for the year ending 2024-03-31 was Rs 16.53 Cr and Rs 5.46 Cr on Consolidated basis. Last Quarter 2024-06-30, Jupiter Infomed reported an income of Rs 5.18 Cr and profit of Rs 2.77 Cr.
- 7. What is the CAGR of Jupiter Infomed?The CAGR of Jupiter Infomed is 49.02.
- 8. What are the returns for Jupiter Infomed share?Return Performance of Jupiter Infomed Shares:
- 1 Week: Jupiter Infomed share price moved up by 3.37%
- 3 Month: Jupiter Infomed share price moved up by 15.16%
- 6 Month: Jupiter Infomed share price moved down by 7.20%
- 9. What is the PE & PB ratio of Jupiter Infomed?The PE ratio of Jupiter Infomed stands at 6.24, while the PB ratio is 1.24.
- 10. What are the key metrics to analyse Jupiter Infomed Share Price?Key Metrics for Jupiter Infomed are:
- PE Ratio of Jupiter Infomed is 6.25
- Price/Sales ratio of Jupiter Infomed is 7.53
- Price to Book ratio of Jupiter Infomed is 1.24
- 11. Which are the key peers to Jupiter Infomed?Top 10 Peers for Jupiter Infomed are Citizen Infoline Ltd., Rap Media Ltd., Esha Media Research Ltd., Real Eco-Energy Ltd., Nouveau Global Ventures Ltd., Vision Cinemas Ltd., Purple Entertainment Ltd., Universal Arts Ltd., Khyati Multimedia Entertainment Ltd. and Kome-on Communication Ltd.
- 12. What dividend is Jupiter Infomed giving?Jupiter Infomedia Ltd. announced an equity dividend of 1% on a face value of 10.0 amounting to Rs 0.1 per share on 15 May 2017. The ex dividend date was 20 Sep 2017.
Trending in Markets
Jupiter Infomed Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.